As of June, 5 The EPS for Calavo Growers, Inc. (CVGW) Expected At $0.84

May 17, 2018 - By Michele Cranor

Calavo Growers, Inc. (NASDAQ:CVGW) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 1.23. That’s change of 0.42, from 2017Q3’s 1.65. 11 investors sold all, 62 reduced holdings as Calavo Growers, Inc. ratio dropped. 55 grew stakes while 35 funds bought stakes. Funds hold 15.14 million shares thus 2.63% less from 2017Q3’s 15.54 million shares.
Goldman Sachs has 42,848 shs for 0% of their capital. Walleye Trading Llc has invested 0% of its capital in Calavo Growers, Inc. (NASDAQ:CVGW). Ameriprise Financial Inc owns 94,657 shs or 0% of their US capital. Renaissance Limited Co accumulated 5,789 shs. Geode Cap Llc holds 0% in Calavo Growers, Inc. (NASDAQ:CVGW) or 138,726 shs. Tudor Inv Corporation Et Al reported 0.01% stake. The Connecticut-based Cardinal Capital Management Lc Ct has invested 1.55% in Calavo Growers, Inc. (NASDAQ:CVGW). Eagle Asset Inc reported 44,284 shs or 0.02% of all its holdings. Ellington Limited Liability Company holds 0.03% of its capital in Calavo Growers, Inc. (NASDAQ:CVGW) for 2,400 shs. Envestnet Asset Management holds 0% of its capital in Calavo Growers, Inc. (NASDAQ:CVGW) for 10,568 shs. Teacher Retirement Of Texas holds 0% of its capital in Calavo Growers, Inc. (NASDAQ:CVGW) for 5,440 shs. Panagora Asset Mngmt Incorporated holds 43,341 shs or 0.01% of its capital. 20,898 are held by Great West Life Assurance Co Can. Teachers Retirement System Of The State Of Kentucky invested 0.01% in Calavo Growers, Inc. (NASDAQ:CVGW). Driehaus Capital Mgmt Ltd invested in 92,008 shs or 0.29% of the stock.

Calavo Growers, Inc. registered $2.17 million net activity with 0 insider purchases and 4 insider sales since December 26, 2017. Another trade for 7,500 shs valued at $692,333 was sold by LEAVENS J LINK. On Tuesday, January 2 $85,050 worth of stock was sold by Brown Marc Laurence. The insider Browne Michael A sold 6,500 shs worth $598,988.

On June, 5 is anticipated Calavo Growers, Inc. (NASDAQ:CVGW)’s earnings report, Faxor reports. The EPS diference is $0.10 or 13.51 % up from last years number. Previous year: $0.74; Analysts forcast: $0.84. In case of $0.84 EPS CVGW’s profit could be $14.74M. Last quarter $0.54 EPS was reported. Analysts sees 55.56 % EPS growth this quarter. CVGW is hitting $96.65 during the last trading session, after increased 3.15%.Calavo Growers, Inc. is uptrending after having risen 52.39% since May 17, 2017. CVGW has 274,815 volume or 84.29% up from normal. The stock outperformed the S&P500 by 40.84%.

Calavo Growers, Inc. (NASDAQ:CVGW) Ratings Coverage

In total 3 analysts cover Calavo Growers (NASDAQ:CVGW). “Buy” rating has 3, “Sell” are 0, while 0 are “Hold”. (NASDAQ:CVGW) has 100% bullish analysts. 4 are the (NASDAQ:CVGW)’s ratings reports on May 17, 2018 according to StockzIntelligence Inc. On Thursday, March 8 the stock of Calavo Growers, Inc. (NASDAQ:CVGW) earned “Buy” rating by Buckingham Research. In Wednesday, March 21 report Stephens maintained it with “Buy” rating and $100.0 target. On Wednesday, December 6 the stock has “Buy” rating by Stephens.

Calavo Growers, Inc. markets and distributes avocados, prepared avocados, and other perishable foods to food distributors, produce wholesalers, supermarkets, convenience stores, and restaurants worldwide.The firm is worth $1.70 billion. It operates in three divisions: Fresh Products, Calavo Foods, and RFG.The P/E ratio is 43.17. The Fresh products segment distributes avocados and other fresh produce products; and procures avocados grown in Mexico, as well as various other commodities, including tomatoes, papayas, and pineapples.

There’s a substantial Calavo Growers, Inc. (NASDAQ:CVGW) news posted by It’s an item titled: “Recent Analysis Shows Lancaster Colony, Calavo Growers, Acuity Brands, Cyclacel Pharmaceuticals, Enbridge …” on May 04, 2018.

Calavo Growers, Inc. (NASDAQ:CVGW) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: